Scilex Holding (SCLX) Cash & Equivalents (2020 - 2026)
Scilex Holding (SCLX) posted Cash & Equivalents of $600,000 for Q2 2026, down 85.4% from $4.1 million a year earlier and down 82.4% from the prior quarter.
Scilex Holding (SCLX) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Scilex Holding's Cash & Equivalents came in at $4.96 million, up 51.4% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 176.8% (FY2020 to FY2025).
- In prior years, Scilex Holding's Cash & Equivalents was $3.27 million in FY2024 (-16.6%), $3.92 million in FY2023 (+79.5%), $2.18 million in FY2022 (-49.7%) and $4.34 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q3 2024.
- On a year-over-year basis, Cash & Equivalents increased in three of the last eight quarters, with growth averaging 98.9%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2025, with growth of 800.0%; the weakest was Q3 2024, with a decline of 95.0%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $3.4 million (Q1 2026), $4.96 million (Q4 2025) and $900,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Scilex Holding | 31.30 Mn | 19.28 Mn | 3.97 Mn | 600,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 600,000.00 |
| Mar 31, 2026 | 3.40 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Dec 31, 2024 | 3.27 Mn |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 6.90 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 34.12 Mn |
| Mar 31, 2023 | 5.10 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 34,961.00 |
| Jun 30, 2022 | 351,272.00 |
| Mar 31, 2022 | 127,440.00 |
| Dec 31, 2021 | 4.34 Mn |
| Sep 30, 2021 | 115,642.00 |
Scilex Holding Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SCLX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SCLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SCLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();